E Fund Management Co., Ltd. Iovance Biotherapeutics, Inc. Transaction History
E Fund Management Co., Ltd.
- $1.93 Billion
- Q3 2024
A detailed history of E Fund Management Co., Ltd. transactions in Iovance Biotherapeutics, Inc. stock. As of the latest transaction made, E Fund Management Co., Ltd. holds 41,952 shares of IOVA stock, worth $268,492. This represents 0.02% of its overall portfolio holdings.
Number of Shares
41,952
Previous 40,912
2.54%
Holding current value
$268,492
Previous $328,000
19.82%
% of portfolio
0.02%
Previous 0.02%
Shares
12 transactions
Others Institutions Holding IOVA
# of Institutions
312Shares Held
237MCall Options Held
3.77MPut Options Held
1.7M-
Vanguard Group Inc Valley Forge, PA27.3MShares$175 Million0.0% of portfolio
-
Perceptive Advisors LLC New York, NY26.6MShares$170 Million6.53% of portfolio
-
Mhr Fund Management LLC New York, NY24MShares$154 Million28.52% of portfolio
-
Black Rock Inc. New York, NY21.2MShares$136 Million0.0% of portfolio
-
State Street Corp Boston, MA13.2MShares$84.5 Million0.01% of portfolio
About IOVANCE BIOTHERAPEUTICS, INC.
- Ticker IOVA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 157,800,992
- Market Cap $1.01B
- Description
- Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...